Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (311-320 of 369) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapyNilofer S Azad, Jeanny B Aragon-Ching, William L Dahut, et al.
Proteomics|September 16, 2003
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancerPaul C Herrmann, John W Gillespie, Lu Charboneau, et al.
JAMA Network Open|October 27, 2021
Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020Satya Das, Liping Du, Cody L Lee, et al.
Cancer|January 3, 2013
Feasibility and safety of sequential research-related tumor core biopsies in clinical trialsJung-min Lee, John L Hays, Anne M Noonan, et al.
Journal of the National Cancer Institute|April 10, 2025
A working group report from the 2024 NCI/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy eraCasey M Cosgrove, Dmitriy Zamarin, Jose R Conejo-Garcia, et al.
Oncotarget|May 14, 2019
Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic riskErika J Lampert, John L Hays, Elise C Kohn, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Gynecologic Oncology|February 15, 2003
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancerLance A Liotta, Emanuel F Petricoin, Ali M Ardekani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancerMonica Brown Jones, Chad M Michener, James O Blanchette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2020
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelinePanagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, et al.
Pageof 37

Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapyNilofer S Azad, Jeanny B Aragon-Ching, William L Dahut, et al.
Proteomics|September 16, 2003
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancerPaul C Herrmann, John W Gillespie, Lu Charboneau, et al.
JAMA Network Open|October 27, 2021
Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020Satya Das, Liping Du, Cody L Lee, et al.
Cancer|January 3, 2013
Feasibility and safety of sequential research-related tumor core biopsies in clinical trialsJung-min Lee, John L Hays, Anne M Noonan, et al.
Journal of the National Cancer Institute|April 10, 2025
A working group report from the 2024 NCI/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy eraCasey M Cosgrove, Dmitriy Zamarin, Jose R Conejo-Garcia, et al.
Oncotarget|May 14, 2019
Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic riskErika J Lampert, John L Hays, Elise C Kohn, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Gynecologic Oncology|February 15, 2003
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancerLance A Liotta, Emanuel F Petricoin, Ali M Ardekani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancerMonica Brown Jones, Chad M Michener, James O Blanchette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2020
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelinePanagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, et al.
Pageof 37